Документ не применяется. Подробнее см. Справку

Список литературы

1. И.Е. Чазова, С.Н. Авдеев, Н.А. Царева, А.В. Волков, Т.В. Мартынюк, С.Н. Наконечников. Клинические рекомендации по диагностике и лечению легочной гипертонии. Терапевтический архив 2014; 9: 4 - 23.

2. Konstantinides CV, Torbick A, Giancarlo Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033 - 3080.

3. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015; 46(4): 903 - 75.

4. Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62: D92 - D99.

5. Wilkens H, (http://www.ncbi.nlm.nih.gov/pubmed/?term=Wilkens%20H%5bAuthor%5d&cauthor=true&cauthor_uid=22221974)LangI, (http://www.ncbi.nlm.nih.gov/pubmed/?term=Lang%20I%5bAuthor%5d&cauthor=true&cauthor_uid=22221974)Behr 1, et al. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension.Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011.

(http://www.ncbi.nlm.nih.gov/pubmed/?term=Behr%20J%5bAuthor%5d&cauthor=true&cauthor_uid=22221974)Respir (http://www.ncbi.nlm.nih.gov/pubmed/23978639)Investig (http://www.ncbi.nlm.nih.gov/pubmed/23978639). 2013 Sep; 51(3) 434 - 46. (http://www.ncbi.nlm.nih.gov/pubmed/23978639)

6. Mehta S, (http://www.ncbi.nlm.nih.gov/pubmed/?term=Mehta%20S%5bAuthor%5d&cauthor=true&cauthor_uid=21165353)Helmersen (http://www.ncbi.nlm.nih.gov/pubmed/?term=Helmersen%20D%5bAuthor%5d&cauthor=true&cauthor_uid=21165353)D, (http://www.ncbi.nlm.nih.gov/pubmed/?term=Helmersen%20D%5bAuthor%5d&cauthor=true&cauthor_uid=21165353)Provencher (http://www.ncbi.nlm.nih.gov/pubmed/?term=Provencher%20S%5bAuthor%5d&cauthor=true&cauthor_uid=21165353)S, et al. Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

(http://www.ncbi.nlm.nih.gov/pubmed/?term=Provencher%20S%5bAuthor%5d&cauthor=true&cauthor_uid=21165353)Can (http://www.ncbi.nlm.nih.gov/pubmed/21165353)Respir (http://www.ncbi.nlm.nih.gov/pubmed/21165353) J. 2010; 17(6): 301 - 34. (http://www.ncbi.nlm.nih.gov/pubmed/21165353)

7. Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124: 1973 - 1981. (http://www.ncbi.nlm.nih.gov/pubmed/21165353)

8. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl I Med 2004; 350: 2257 - 2264. (http://www.ncbi.nlm.nih.gov/pubmed/21165353)

9. Lang I, Simonneau G, Pepke-Zaba I, et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension: a case-control study. Thromb Haemost 2013; 110: 83 - 91.

(http://www.ncbi.nlm.nih.gov/pubmed/21165353)

10. Jenkins D, Mayer E, Screaton N, Madani M. State-of-the-art chronic thromboembolic

(http://www.ncbi.nlm.nih.gov/pubmed/21165353) pulmonary hypertension: diagnosis and management. Eur Respir Rev 2012; 21: 32 - 39.

(http://www.ncbi.nlm.nih.gov/pubmed/21165353)

11. Tunariu N, Gibbs S, Win Z, et al. Ventilation-perfusion scintigraphy Is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. I Nucl Med 2007; 48: 680 - 684.

12. Lang IM, Plank C, Sadushi-Kolici R, et al. Imaging in pulmonary hypertension. JACC Cardiovasc Imaging 2010; 3: 1287 - 1295.

13. Guerin L, Couturaud F, Parent F, et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost 2014; 112: 598 - 605.

14. Ley S, Ley-Zaporozhan I, Pitton MB, et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 2012; 22: 607 - 616.

15. Bergin CJ, Sirlin S, Hauschildt I, et al. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology 1997; 204: 695 - 702.

16. Skoro-Sajer N, Marta G, Gerges C, et al. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax 2014; 69: 116 - 122.

17. Pepke-Zaba J, Hoeper MM, Humbert M. Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Respir I 2013; 41: 8 - 9.

18. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006; 114: 1482 - 1489.

19. The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. EurHeartJ 2003; 24: 761 - 781.

20. Мершин К.В., Акчурин Р.С. Глава "Хроническая тромбоэмболическая легочная гипертензия"./ Монография "Легочная гипертензия". Под редакцией И.Е. Чазовой, Т.В. Мартынюк. Москва. Практика. 2015; 563 - 606.

21. Чернявский А.М. Глава "Хроническая постэмболическая легочная гипертензия"/Монография "Легочная гипертензия". Под редакцией С.Н. Авдеева. Москва. ГЭОТАР - Медиа. 2015; 281 - 323.

22. McNeil (http://www.ncbi.nlm.nih.gov/pubmed/?term=McNeil%20K%5Bauth%5D)K., Dunning (http://www.ncbi.nlm.nih.gov/pubmed/?term=Dunning%201%5Bauth%5D)l.Chronicthromboembolicpulmonaryhypertension (CTEPH) Heart. 2007 Sep; 93(9): 1152 - 1158.

23. Berman M, Tsui S, Vuylsteke A, et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg 2008; 86: 1261 - 1267.

24. Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702 - 710.

25. Thistlethwaite P.A, Madani M.M, Kemp A.D, et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. AnnThoracSurg 2006; 82: 2139 - 2145.

26. Мершин К.В., Мартынюк Т.В. Место медикаментозной терапии в лечении хронической тромбоэмболической легочной гипертензии. Евразийский кардиологический журнал. 2014; 1: 113 - 118.

27. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronicthromboembolicpulmonaryhypertension. Circulation 2006; 113: 2011 - 2020.

28. Ghofrani HA, Hoeper MM, Halank M, et al. Riociguat for chronic Thromboembolic pulmonary hypertension and pulmonary arterial hypertension: A phase II study. Eur Respir I. 2010; 36: 792 - 9.

29. Ghofrani HA, DArmini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369: 319 - 329.

30. Skoro-Sajer N, Bonderman D, Wiesbauer F, et al. Treprostinil for severe inoperable chronic thromboembolicpulmonary hypertension.ThrombHaemost 2007; 5: 483 - 489.

31. Olschewski H (http://www.ncbi.nlm.nih.gov/pubmed/?term=Olschewski%20H%5BAuthor%5D&cauthor=true&cauthor_uid=12151469), Simonneau G (http://www.ncbi.nlm.nih.gov/pubmed/?term=Simonneau%20G%5B Author%5D &cauthor=true &cauthor_uid=12151469), 00000004.wmz (http://www.ncbi.nlm.nih.gov/pubmed/?term=Gali%C3%A8%20N%5BAuthor%5D&cauthor=true&cauthor_uid=12151469), et al. Inhaled iloprost for severe pulmonary hypertension. N Engl I Med. (http://www.ncbi.nlm.nih.gov/pubmed/12151469) 2002; 347(5): 322 - 9.

32. Jai's X, D'Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am CollCardiol 2008;52:2127-2134.

33. 00000005.wmz (http://www.ncbi.nlm.nih.gov/pubmed/?term=Gali%C3%A8%20N%5BAuthor%5D&cauthor=true&cauthor_uid=16291984), Ghofrani HA (http://www.ncbi.nlm.nih.gov/pubmed/?term=Ghofrani%20HA%5B Author%5D &cauthor=true &cauthor_uid=16291984), Torbicki A (http://www.ncbi.nlm.nih.gov/pubmed/?term=Torbicki%20A%5B Author%5D &cauthor=true &cauthor_uid=16291984), et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N EnglJ Med. (http://www.ncbi.nlm.nih.gov/pubmed/16291984) 2005; 353(20): 2148 - 57.

34. Reichenberger F, Voswinckel R, Enke B, et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007; 30: 922 - 927.

35. Kataoka M, Inami T, Hayashida K, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5: 756 - 762.

36. Sugimura K, Fukumoto Y, Satoh K, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circl 2012; 76: 485 - 488.

37. Данилов Н.М. (http://www.fesmu.ru/elib/search.aspx?author=%22%C4%E0%ED%E8%EB%EE%E2%20%CD.%CC.%22), Матчин Ю.Г. (http://www.fesmu.ru/elib/search.aspx?author=%22%CC%E0%F2%F7%E8%ED%20%DE.%C3.%22), Мартынюк T.B. (http://www.fesmu.ru/elib/search.aspx?author=%22%CC%E0%F0%F2%FB%ED%FE%EA%20%D2.%C2.%22), др. Транслюминальная баллонная ангиопластика легочных артерий у больных с неоперабельной хронической тромбоэмболической легочной гипертензией (первый опыт в России). Consilium medicum 2015; 10: 61 - 66.

38. Inami T, Kataoka M, Shimura N, et al. Pulmonary edema predictive scoring index (PEPSI), a new indexto predict risk of reperfusion pulmonary edema and improvement of hemodynamicsin percutaneous transluminal pulmonary angioplasty. IACC Cardiovasc Interv 2013; 6: 725 - 736.

39. Revel MP, Sanchez O, Couchon S, Planquette B, Hernigou A, Niarra R, Meyer G, Chatellier G. Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the "IRM-EP" study. I Thromb Haemost 2012; 10(5): 743 - 750.

40. Stein PD, Chenevert TL, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, lablonski KA, Leeper KV Ir., Naidich DP, Sak DJ, Sostman HD, Tapson VF, Weg IG, Woodard PK. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010; 152(7): 434 - 3.

41. van Belle A, Bu'ller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, Kramer MH, Kruip MJ, Kwakkel-van Erp IM, Leebeek FW, Nijkeuter M, Prins MH, Sohne M, Tick LW. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295(2): 172 - 179.